Table 2.
Characteristics of SARS-CoV-2 infected patients by race/ethnicity
| Hispanic No. (%) | Black No. (%) | Asian No. (%) | NH/PI No. (%) | AI/AN No. (%) | White No. (%) | Other No. (%) | Unknown No. (%) | |
|---|---|---|---|---|---|---|---|---|
| Socio-demographics | ||||||||
| Total no. of patients | 16,836 | 2,066 | 2,456 | 468 | 434 | 24,468 | 2,353 | 5,564 |
| Hospitalized | 2,898 (17.2%) | 368 (17.8%) | 533 (21.7%) | 98 (20.9%) | 77 (17.7%) | 3,751 (15.3%) | 485 (20.6%) | 326 (5.9%) |
| Age (years) | 44.7 ± 17.3 | 46.4 ± 18.5 | 51.7 ± 19.4 | 45.6 ± 16.5 | 44.8 ± 17.9 | 51.1 ± 20.3 | 49.7 ± 19.1 | 41.8 ± 17.4 |
| Sex | ||||||||
| Female | 9,064 (53.8%) | 1,080 (52.3%) | 1,347 (54.8%) | 262 (56.0%) | 252 (58.1%) | 12,842 (52.5%) | 1,181 (50.2%) | 2,737 (49.2%) |
| Male | 7,772 (46.2%) | 986 (47.7%) | 1,109 (45.2%) | 206 (44.0%) | 182 (41.9%) | 11,626 (47.5%) | 1,172 (49.8%) | 2,827 (50.8%) |
| Insurance | ||||||||
| Commercial | 5,878/16,192 (36.3%) | 688/2,015 (34.1%) | 1,226/2,401 (51.1%) | 195/457 (42.7%) | 113/424 (26.7%) | 11,513/24,077 (47.8%) | 904/2,271 (39.8%) | 3,100/4,927 (62.9%) |
| Medicaid | 8,751/16,192 (54.0%) | 1,119/2,015 (55.5%) | 861/2,401 (35.9%) | 204/457 (44.6%) | 260/424 (61.3%) | 7,464/24,077 (31.0%) | 1,108/2,271 (48.8%) | 1,170/4,927 (23.7%) |
| Medicare | 863/16,192 (5.3%) | 168/2,015 (8.3%) | 290/2,401 (12.1%) | 41/457 (9.0%) | 51/424 (12.0%) | 4,964/24,077 (20.6%) | 214/2,271 (9.4%) | 398/4,927 (8.1%) |
| Uninsured/Self-pay | 693/16,192 (4.3%) | 40/2,015 (2.0%) | 23/2,401 (1.0%) | 17/457 (3.7%) | 0 (0.0%) | 135/24,077 (0.6%) | 44/2,271 (1.9%) | 259/4,927 (5.3%) |
| Other insurance | 7/16,192 (0.0%) | 0 (0.0%) | 1/2,401 (0.0%) | 0 (0.0%) | 0 (0.0%) | 1/24,077 (0.0%) | 1/2,271 (0.0%) | 0 (0.0%) |
| Neighborhood-level | ||||||||
| Median income | 63,454 ± 17,110 | 65,525 ± 19,805 | 74,491 ± 23,569 | 65,528 ± 20,276 | 68,286 ± 18,073 | 70,511 ± 22,886 | 71,427 ± 23,518 | 72,630 ± 23,845 |
| % Crowded housing | 10.3 ± 7.8 | 6.9 ± 6.0 | 5.7 ± 4.8 | 5.2 ± 4.8 | 3.6 ± 2.7 | 3.7 ± 3.7 | 6.2 ± 5.4 | 6.5 ± 6.7 |
| % Minority | 59.0 ± 27.2 | 53.0 ± 26.7 | 45.8 ± 21.0 | 39.0 ± 22.0 | 29.5 ± 15.9 | 29.2 ± 18.3 | 44.7 ± 22.5 | 44.7 ± 26.1 |
| % Limited English | 19.2 ± 11.0 | 14.5 ± 9.3 | 14.0 ± 8.7 | 11.1 ± 8.4 | 6.2 ± 5.2 | 8.0 ± 7.7 | 14.4 ± 9.8 | 12.9 ± 10.5 |
| Comorbidities | ||||||||
| Hypertension | 2,726 (16.2%) | 585 (28.3%) | 620 (25.2%) | 117 (25.0%) | 113 (26.0%) | 5,718 (23.4%) | 464 (19.7%) | 504 (9.1%) |
| Diabetes | 2,025 (12.0%) | 338 (16.4%) | 387 (15.8%) | 105 (22.4%) | 63 (14.5%) | 2,496 (10.2%) | 267 (11.3%) | 265 (4.8%) |
| BMI | ||||||||
| Underweight | 147/15,062 (1.0%) | 40/1,832 (2.2%) | 88/2,162 (4.1%) | 6/423 (1.4%) | 6/391 (1.5%) | 401/21,621 (1.9%) | 37/2,088 (1.8%) | 56/3,605 (1.6%) |
| Normal | 2,519/15,062 (16.7%) | 416/1,832 (22.7%) | 976/2,162 (45.1%) | 81/423 (19.1%) | 70/391 (17.9%) | 5,713/21,621 (26.4%) | 527/2,088 (25.2%) | 975/3,605 (27.0%) |
| Overweight | 5,132/15,062 (34.1%) | 557/1,832 (30.4%) | 722/2,162 (33.4%) | 112/423 (26.5%) | 98/391 (25.1%) | 6,780/21,621 (31.4%) | 706/2,088 (33.8%) | 1,256/3,605 (34.8%) |
| Class 1 Obesity | 4,002/15,062 (26.6%) | 401/1,832 (21.9%) | 263/2,162 (12.2%) | 97/423 (22.9%) | 97/391 (24.8%) | 4,462/21,621 (20.6%) | 470/2,088 (22.5%) | 707/3,605 (19.6%) |
| Class 2 Obesity | 1,887/15,062 (12.5%) | 215/1,832 (11.7%) | 70/2,162 (3.2%) | 58/423 (13.7%) | 56/391 (14.3%) | 2,346/21,621 (10.9%) | 209/2,088 (10.0%) | 373/3,605 (10.3%) |
| Class 3 Obesity | 1,375/15,062 (9.1%) | 203/1,832 (11.1%) | 43/2,162 (2.0%) | 69/423 (16.3%) | 64/391 (16.4%) | 1,919/21,621 (8.9%) | 139/2,088 (6.7%) | 238/3,605 (6.6%) |
| Chronic respiratory disease | ||||||||
| Asthma | 731 (4.3%) | 164 (7.9%) | 135 (5.5%) | 30 (6.4%) | 63 (14.5%) | 1,506 (6.2%) | 104 (4.4%) | 161 (2.9%) |
| COPD | 133 (0.8%) | 71 (3.4%) | 40 (1.6%) | 7 (1.5%) | 28 (6.5%) | 1,056 (4.3%) | 52 (2.2%) | 37 (0.7%) |
| Cardiovascular disease | ||||||||
| Coronary artery disease | 281 (1.7%) | 54 (2.6%) | 97 (3.9%) | 26 (5.6%) | 17 (3.9%) | 1,346 (5.5%) | 86 (3.7%) | 69 (1.2%) |
| Myocardial Infarction | 170 (1.0%) | 46 (2.2%) | 52 (2.1%) | 14 (3.0%) | 9 (2.1%) | 495 (2.0%) | 45 (1.9%) | 41 (0.7%) |
| Congestive heart failure | 374 (2.2%) | 111 (5.4%) | 90 (3.7%) | 22 (4.7%) | 25 (5.8%) | 1,328 (5.4%) | 102 (4.3%) | 76 (1.4%) |
| Kidney disease | 755 (4.5%) | 170 (8.2%) | 159 (6.5%) | 46 (9.8%) | 29 (6.7%) | 1,530 (6.3%) | 117 (5.0%) | 91 (1.6%) |
| Liver disease | 474 (2.8%) | 45 (2.2%) | 93 (3.8%) | 13 (2.8%) | 27 (6.2%) | 592 (2.4%) | 50 (2.1%) | 59 (1.1%) |
| Cancer | 323 (1.9%) | 60 (2.9%) | 77 (3.1%) | 7 (1.5%) | 16 (3.7%) | 1,069 (4.4%) | 44 (1.9%) | 67 (1.2%) |
| Charlson Comorbidity Index | 0.0 (0.0 – 2.0) | 1.0 (0.0 – 3.0) | 1.0 (0.0 – 3.0) | 0.0 (0.0 – 2.0) | 1.0 (0.0 – 3.0) | 1.0 (0.0 – 3.0) | 1.0 (0.0 – 3.0) | 0.0 (0.0 – 1.0) |
| Location of Testing | ||||||||
| Emergency | 5,114 (30.4%) | 652 (31.6%) | 422 (17.2%) | 117 (25.0%) | 70 (16.1%) | 3,367 (13.8%) | 663 (28.2%) | 371 (6.7%) |
| Inpatient | 2,854 (17.0%) | 385 (18.6%) | 538 (21.9%) | 98 (20.9%) | 73 (16.8%) | 3,994 (16.3%) | 503 (21.4%) | 343 (6.2%) |
| Urgent care | 4,142 (24.6%) | 390 (18.9%) | 628 (25.6%) | 106 (22.6%) | 70 (16.1%) | 8,029 (32.8%) | 538 (22.9%) | 1,322 (23.8%) |
| Other outpatient | 4,165 (24.7%) | 564 (27.3%) | 792 (32.2%) | 124 (26.5%) | 204 (47.0%) | 7,723 (31.6%) | 566 (24.1%) | 3,167 (56.9%) |
| Other service area | 561 (3.3%) | 74 (3.6%) | 75 (3.1%) | 23 (4.9%) | 17 (3.9%) | 1,355 (5.5%) | 83 (3.5%) | 361 (6.5%) |